NASDAQ · Dividend

Eton Pharmaceuticals, Inc. (ETON) Dividend

$63.65 NASDAQ: ETON Market Cap $1.84B

Data as of Nov 17, 2026 close · Source: Financial Modeling Prep (methodology)

MetricValue
Dividend YieldNone
Indicated Annual Dividend—
Payout Ratio—
FCF Yield2.16%
Current Price$63.65

Dividend Analysis

Eton Pharmaceuticals, Inc. (ETON) does not currently pay a dividend, based on the latest available data. Companies that do not pay dividends may use earnings for reinvestment, acquisitions, share buybacks, or debt repayment instead.

Free cash flow yield of 2.16% covers the 0.00% dividend yield.

Dividend yield against peers

Eton Pharmaceuticals, Inc. has the lowest dividend yield of the 9 companies compared here.

CompanyYieldP/EPrice
Zoetis Inc. (ZTS)2.60%13.82$83.48
Viatris Inc. (VTRS)2.28%—$20.45
Dr. Reddy's Laboratories Ltd (RDY)0.57%39.94$14.79
Teva Pharmaceutical Industries Limited (TEVA)0.00%94.73$42.62
Elanco Animal Health Incorporated (ELAN)0.00%—$25.85
Alkermes plc (ALKS)0.00%—$45.45
Amneal Pharmaceuticals, Inc. (AMRX)0.00%50.49$21.12
Lantheus Holdings, Inc. (LNTH)0.00%24.54$101.80
Eton Pharmaceuticals, Inc. (ETON)0.00%34.82$63.65

Eton Pharmaceuticals, Inc. (ETON) dividend — frequently asked questions

Does Eton Pharmaceuticals, Inc. (ETON) pay a dividend?

No, Eton Pharmaceuticals, Inc. (ETON) does not currently pay a dividend.

Dividend yields of other Drug Manufacturers - Specialty & Generic stocks

ZTS yield 2.60%VTRS yield 2.28%RDY yield 0.57%All Drug Manufacturers - Specialty & Generic stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
ETON Overview ETON Financials Screen Dividend Stocks

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.